metaEvidence - overview


			deaths (OS)	progression or deaths (PFS)	RFS/DFS
mNSCLC - L1 - PDL1 positive metastatic/advanced NSCLC (mNSCLC) - 1st line (L1) mNSCLC - L1 - PDL1 positive
versus pemetrexed plus platin
	nivolumab plus ipilimumab vs. pemetrexed plus platin	1	NaN [NaN; NaN] /10000 0/0 vs. 0/0	NaN [NaN; NaN] /10000 0/0 vs. 0/0	-